ZA862947B - Drug depotcontaining cytostatics - Google Patents
Drug depotcontaining cytostaticsInfo
- Publication number
- ZA862947B ZA862947B ZA862947A ZA862947A ZA862947B ZA 862947 B ZA862947 B ZA 862947B ZA 862947 A ZA862947 A ZA 862947A ZA 862947 A ZA862947 A ZA 862947A ZA 862947 B ZA862947 B ZA 862947B
- Authority
- ZA
- South Africa
- Prior art keywords
- cytostatics
- drug
- depotcontaining
- depot
- cytostatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
- A61L2300/406—Antibiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Materials Engineering (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19853513938 DE3513938A1 (de) | 1985-04-18 | 1985-04-18 | Cytostatikahaltiges pharmakadepot |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA862947B true ZA862947B (en) | 1987-09-30 |
Family
ID=6268411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA862947A ZA862947B (en) | 1985-04-18 | 1986-04-18 | Drug depotcontaining cytostatics |
Country Status (11)
Country | Link |
---|---|
US (1) | US4797282A (ja) |
EP (1) | EP0202445B1 (ja) |
JP (1) | JPS61243015A (ja) |
AT (1) | ATE60904T1 (ja) |
AU (1) | AU587432B2 (ja) |
CA (1) | CA1282330C (ja) |
DE (2) | DE3513938A1 (ja) |
ES (1) | ES8801988A1 (ja) |
HU (1) | HU198383B (ja) |
IE (1) | IE57523B1 (ja) |
ZA (1) | ZA862947B (ja) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5286763A (en) * | 1983-03-22 | 1994-02-15 | Massachusetts Institute Of Technology | Bioerodible polymers for drug delivery in bone |
DE3613213A1 (de) * | 1986-04-18 | 1987-10-22 | Merck Patent Gmbh | Tricalciumphosphat fuer implantationsmaterialien |
DE3901551A1 (de) * | 1989-01-20 | 1990-07-26 | Lohmann Therapie Syst Lts | Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil |
US5356630A (en) * | 1989-02-22 | 1994-10-18 | Massachusetts Institute Of Technology | Delivery system for controlled release of bioactive factors |
US5051257A (en) * | 1989-05-09 | 1991-09-24 | Pietronigro Dennis D | Antineoplastic solution and method for treating neoplasms |
DE4019617A1 (de) * | 1990-06-20 | 1992-01-02 | Thera Ges Fuer Patente | Implantierbares wirkstoffdepotmaterial |
DE4033308A1 (de) * | 1990-10-19 | 1992-04-23 | Draenert Klaus | Implantat und verfahren zu seiner herstellung |
DE4407484A1 (de) * | 1993-12-03 | 1995-06-08 | Werner Prof Dr Kreutz | Medikament zur Krebs-Therapie |
DE4433201A1 (de) | 1994-09-17 | 1996-03-21 | Merck Patent Gmbh | Verfahren zur Herstellung von wirkstoffhaltigen Knochenzementen |
DE19511663A1 (de) * | 1995-03-30 | 1996-10-02 | Merck Patent Gmbh | Mittelbrechende optische Schichten |
DE19527306C1 (de) * | 1995-07-26 | 1997-02-27 | Haerle Anton | Pharmakafreisetzende Körperchen |
US5951588A (en) * | 1996-02-29 | 1999-09-14 | Moenning; Stephen P. | Apparatus and method for protecting a port site opening in the wall of a body cavity |
US6485514B1 (en) | 1997-12-12 | 2002-11-26 | Supergen, Inc. | Local delivery of therapeutic agents |
US6455064B1 (en) | 1998-04-30 | 2002-09-24 | Closure Medical Corporation | Method of applying an adhesive composition over a bioactive polymerization initiator or accelerator |
CA2330479A1 (en) * | 1998-04-30 | 1999-11-04 | Upvan Narang | Use of an adhesive composition over a bioactive polymerization initiator or accelerator |
US20050196431A1 (en) * | 1998-04-30 | 2005-09-08 | Upvan Narang | Adhesive applicator tip with a polymerization initiator, polymerization rate modifier, and/or bioactive material |
US6166007A (en) | 1998-07-02 | 2000-12-26 | Sodemann; Klaus | Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof |
US6361731B1 (en) | 1998-07-15 | 2002-03-26 | Biomet, Inc. | Method of forming a temporary implant |
US6155812A (en) * | 1998-07-15 | 2000-12-05 | Biomet, Inc | Cement mold for a temporary implant |
US6679870B1 (en) | 1999-07-23 | 2004-01-20 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US6685694B2 (en) | 1999-07-23 | 2004-02-03 | Vasca, Inc. | Methods and kits for locking and disinfecting implanted catheters |
US6579469B1 (en) | 1999-10-29 | 2003-06-17 | Closure Medical Corporation | Cyanoacrylate solutions containing preservatives |
EP1245247A1 (en) | 2001-03-28 | 2002-10-02 | Biolink Corporation | Biocidal locks |
WO2003022260A1 (en) * | 2001-09-12 | 2003-03-20 | Slobodan Arsenijevic | Use of methotrexate and l-arginine for the preparation of a medicament for treatment of uterine myoma |
US20050203217A1 (en) * | 2002-04-30 | 2005-09-15 | Pomrink Gregory J. | Stabilizers for polymerizable biocompatible materials |
DE10332680A1 (de) * | 2003-07-18 | 2005-02-17 | Biomet Deutschland Gmbh | Verwendung von antiseptischen Wirkstoffen in PMMA-Knochenzementen |
DE102004049121B4 (de) * | 2004-10-07 | 2008-01-10 | Heraeus Kulzer Gmbh | Antibiotikum-/Antibiotika enthaltender PMMA-Knochenzement |
US7696182B2 (en) | 2004-11-02 | 2010-04-13 | Nd Partners, Llc | Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin |
WO2006122414A1 (en) * | 2005-05-17 | 2006-11-23 | Matregen Corp. | Depot for sustained and controlled delivery of methotrexate |
US8206143B2 (en) * | 2007-12-13 | 2012-06-26 | Biomet Manufacturing Corp. | Modular articulating cement spacer |
US9457048B2 (en) | 2008-02-05 | 2016-10-04 | Wellosophy Corporation | Absorbent ingestible agents and associated methods of manufacture and use |
DE102008064036B4 (de) | 2008-12-22 | 2012-06-06 | Heraeus Medical Gmbh | Polymethylmethacrylat-Knochenzement-Zusammensetzung zur kontrollierten Hyperthermiebehandlung und deren Verwendung |
ES2911190T3 (es) | 2010-05-11 | 2022-05-18 | Howmedica Osteonics Corp | Compuestos organofosforados, de metales multivalentes y composiciones y métodos de red interpenetrantes adhesivos poliméricos |
US8765189B2 (en) | 2011-05-13 | 2014-07-01 | Howmedica Osteonic Corp. | Organophosphorous and multivalent metal compound compositions and methods |
US11738120B1 (en) | 2022-04-14 | 2023-08-29 | Cormedix Inc. | Synthesis of taurolidine, purity profiles and polymorphs |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3826678A (en) * | 1972-06-06 | 1974-07-30 | Atomic Energy Commission | Method for preparation of biocompatible and biofunctional materials and product thereof |
DE2511122B2 (de) * | 1975-03-14 | 1977-06-08 | Vorprodukt fuer die zubereitung von knochenzement | |
US4059648A (en) * | 1976-07-09 | 1977-11-22 | Mobil Oil Corporation | Method for upgrading synthetic oils boiling above gasoline boiling material |
DE2651441C2 (de) * | 1976-11-11 | 1987-01-08 | Merck Patent Gmbh, 6100 Darmstadt | Antibioticahaltiges Mittel |
AR216922A1 (es) * | 1976-11-11 | 1980-02-15 | Merck Patent Gmbh | Procedimiento para la fabricacion de un medio quirurgico |
DE2727535C2 (de) * | 1977-06-18 | 1986-09-18 | Merck Patent Gmbh, 6100 Darmstadt | Antibioticahaltiges Mittel |
DE2843963A1 (de) * | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin |
DE2908794C2 (de) * | 1978-03-09 | 1984-09-13 | Japan Atomic Energy Research Institute, Tokio/Tokyo | Verfahren zur Herstellung eines eine physiologisch aktive Substanz enthaltenden Polymerpräparates |
JPS5585516A (en) * | 1978-11-27 | 1980-06-27 | Japan Atom Energy Res Inst | Method of preparing polymer composition containing carcinostatic substance |
DE2905878A1 (de) * | 1979-02-16 | 1980-08-28 | Merck Patent Gmbh | Implantationsmaterialien und verfahren zu ihrer herstellung |
JPS6041048B2 (ja) * | 1980-09-24 | 1985-09-13 | 日本原子力研究所 | 徐放性複合体の製造方法 |
DE3037270A1 (de) * | 1980-10-02 | 1982-05-19 | Ulatowski, Lothar, Dr.med., 5630 Remscheid | Fibrinantibiotikumverbundketten |
DK154260C (da) * | 1981-02-20 | 1989-05-22 | Mundipharma Gmbh | Fremgangsmaade til fremstilling af et knogleimplantat af braendt tricalciumphosphat, specielt til udfyldning af hulrum eller til sammensaetning af knogledele efter fraktur. |
DE3360633D1 (en) * | 1982-02-12 | 1985-10-03 | Unitika Ltd | Anti-cancer device |
JPS5944310A (ja) * | 1982-09-06 | 1984-03-12 | Nippon Kayaku Co Ltd | シリコ−ンゴム系徐放性製剤 |
US4589882A (en) * | 1983-09-19 | 1986-05-20 | Urry Dan W | Enzymatically crosslinked bioelastomers |
US4619913A (en) * | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
-
1985
- 1985-04-18 DE DE19853513938 patent/DE3513938A1/de not_active Withdrawn
-
1986
- 1986-03-12 AU AU54656/86A patent/AU587432B2/en not_active Ceased
- 1986-04-07 AT AT86104723T patent/ATE60904T1/de not_active IP Right Cessation
- 1986-04-07 DE DE8686104723T patent/DE3677545D1/de not_active Expired - Fee Related
- 1986-04-07 EP EP86104723A patent/EP0202445B1/de not_active Expired - Lifetime
- 1986-04-16 CA CA000506775A patent/CA1282330C/en not_active Expired - Fee Related
- 1986-04-17 JP JP61087256A patent/JPS61243015A/ja active Pending
- 1986-04-17 IE IE1018/86A patent/IE57523B1/en not_active IP Right Cessation
- 1986-04-17 HU HU861608A patent/HU198383B/hu not_active IP Right Cessation
- 1986-04-17 ES ES554090A patent/ES8801988A1/es not_active Expired
- 1986-04-18 US US06/853,320 patent/US4797282A/en not_active Expired - Fee Related
- 1986-04-18 ZA ZA862947A patent/ZA862947B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES554090A0 (es) | 1988-03-16 |
AU5465686A (en) | 1986-10-23 |
US4797282A (en) | 1989-01-10 |
IE861018L (en) | 1986-10-18 |
HUT44170A (en) | 1988-02-29 |
DE3677545D1 (de) | 1991-03-28 |
EP0202445A3 (en) | 1987-08-12 |
AU587432B2 (en) | 1989-08-17 |
ATE60904T1 (de) | 1991-03-15 |
DE3513938A1 (de) | 1986-10-23 |
EP0202445A2 (de) | 1986-11-26 |
CA1282330C (en) | 1991-04-02 |
ES8801988A1 (es) | 1988-03-16 |
IE57523B1 (en) | 1992-10-07 |
EP0202445B1 (de) | 1991-02-20 |
HU198383B (en) | 1989-10-30 |
JPS61243015A (ja) | 1986-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA862947B (en) | Drug depotcontaining cytostatics | |
DE3660462D1 (en) | Disposable closure for an intestinal opening | |
NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
ZA898200B (en) | Retainer for surgical sutures | |
EP0602757A3 (en) | System for applying knots in surgical sutures. | |
GR3006630T3 (ja) | ||
DE3060103D1 (en) | Implant for the fixation of rib fractures | |
GB2211489B (en) | Envelope supply pack retainer | |
IL85633A0 (en) | Phenoxyphenylthioureas,phenoxyphenyl-isothioureas and phenoxyphenylcarbodi-imides and use thereof for controlling pests | |
AU6599490A (en) | The use of protected amino acids for feeding sheep | |
ZA888733B (en) | Peptide structures,immunogens containing them and their uses in the control of fertility | |
AU569354B2 (en) | (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane | |
EP0342139A3 (en) | Medicine containing arginine aspartate for treating inflictions of the memory | |
GB2183174B (en) | Breathable backing or release liner and process for forming the same | |
EP0416018A4 (en) | Controlled release fertilizer | |
IL89901A0 (en) | Strobilurine derivatives | |
EP0159602A3 (en) | Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals | |
GB2115393B (en) | Identifying and controlling the movement of containers | |
EP0345358A4 (en) | TARGET MATERIAL FOR FORMING A SUPRAL-CONDUCTING FILM. | |
EP0289247A3 (en) | Fluid transport containers and control means therefor | |
ES1003585Y (es) | Capsula perfeccionada para el cierre de botellas y similares. | |
EP0183922A3 (en) | Process and agent for combating the rhomboid looper boarmia rhomboidaria | |
CS213688A3 (en) | Device for illuminating, radiating or heating of material | |
IT1225299B (it) | Morsetto a bloccaggio rapido | |
CS390487A1 (en) | Pulse-regulated feeding source with current-dependent control |